Pharmaceuticals

Pharma Grade Calcium Sulphate Market Insights On Growth Drivers, Trends, And Opportunities

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Pharma Grade Calcium Sulphate Market Grow Between 2026 And 2030?

The size of the pharma grade calcium sulphate market has experienced significant expansion over recent years. This market is projected to expand from $0.96 billion in 2025 to reach $1.04 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this historical growth include the expansion of pharmaceutical manufacturing, a rise in the demand for solid dosage forms, the increase in generic drug production, the growing application of calcium-based excipients, and a stronger regulatory focus on the quality of excipients.

The pharma grade calcium sulphate market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach $1.44 billion, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected growth during the forecast period stems from factors such as increased global drug manufacturing, the expanding application of high-performance excipients, a greater need for uniform formulation quality, the expansion of nutraceutical production, and ongoing improvements in excipient processing. Key trends foreseen for this period encompass a heightened demand for high-purity pharmaceutical excipients, their broader integration into tablet and capsule formulations, an uptick in their use for calcium supplement production, an increase in quality-controlled excipient manufacturing, and a stronger emphasis on materials that comply with regulations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Primary Drivers Are Shaping The Pharma Grade Calcium Sulphate Market?

The increasing demand for pharmaceuticals is projected to drive the growth of the pharma grade calcium sulphate market in the coming period. Pharmaceuticals are substances, including drugs and medications, that are developed, manufactured, and administered to diagnose, treat, or prevent diseases in both humans and animals. The surge in pharmaceutical demand is primarily attributed to the rising prevalence of chronic conditions, necessitating long-term medications for individuals managing ailments such as diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate plays a crucial role in enhancing pharmaceutical formulations by acting as a high-purity excipient, which ensures consistent tablet hardness, overall stability, and the controlled release of active ingredients. For instance, according to Eurostat, a Luxembourg-based official statistical agency of the European Union, in April 2024, imports of medicinal and pharmaceutical products into the EU saw a 6.1% increase in 2023, amounting to $137.4 billion (€119 billion) when compared to the preceding year. During the same timeframe, EU exports reached $319.2 billion (€277 billion), leading to a trade surplus of $182.0 billion (€158 billion). Therefore, the escalating demand for pharmaceuticals is a significant impetus behind the expansion of the pharma grade calcium sulphate market.

What Segment Categories Shape The Pharma Grade Calcium Sulphate Market Segment Landscape?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

What Trends Are Affecting The Growth Of The Pharma Grade Calcium Sulphate Market?

Companies operating within the pharma grade calcium sulphate market are concentrating on developing innovative products by leveraging synthetic medical-grade bassanite to enhance the purity and consistency of their calcium sulphate offerings. Synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO4·0.5H2O), enables the production of pharma-grade calcium sulphate by supplying a consistent, contaminant-free source that adheres to strict regulatory standards for medical and pharmaceutical applications. For instance, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx, which are innovative drug-eluting bone graft products. These were developed using synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement made from calcium sulfate hemihydrate reinforced with phosphate ions, making it ideal for filling bone defects and delivering drugs at the implantation site for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other liquid medications, facilitating sustained drug release for more than 30 days. These products represent a significant advancement in localized therapy for bone infections and regeneration, illustrating how pharma-grade calcium sulfate can be utilized in next-generation biomedical solutions that meet stringent international standards.

Who Are The Companies Operating Across The Pharma Grade Calcium Sulphate Market Value Chain?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Get The Full Pharma Grade Calcium Sulphate Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Region Is The Largest In The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharma Grade Calcium Sulphate Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795